We do not have data on regional body composition or blood pressure, so we were unable to assess the risk of metabolic syndrome or coronary heart disease or develop predictors for the same in this population; furthermore, we were unable to compare lipid levels with other well-known markers of inflammation (C-reactive protein (CRP) and albumin concentrations) because there is no data from the prospective study. Here, ALB is linked to metabolic syndrome.